1. A. I. Vinik, M. L. Nevoret, C. Casellini, et al., “Diabetic neuropathy,” Endocrinol. Metab. Clin. North Am., 42, No. 4, 747-787 (2013).
2. S. Tesfaye, A. J. M. Boulton, P. J. Dyck, et al., “On behalf of the Toronto diabetic neuropathy expert group. Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, 33, No. 10, 2285-2293 (2010).
3. A. Hosseini and M. Abdollahi, “Diabetic neuropathy and oxidative stress: therapeutic perspectives,” Oxid. Med. Cell. Longev, Publ. online, April 24 (2013).
4. R. V. Stavniichuk and T. M. Kuchmerovs’ka, “Diabetic neuropathy. The role of 12/15 lipoxygenase and metabolism of arachidonic acid,” Endokrinologiya, 19, No. 2, 156-166 (2014).
5. M. M. Guzyk, K. O. Dyakun, L. V. Yanits’ka, and T. M. Kuchmerovs’ka, “Effects of inhibitors of poly(ADP-ribose)polymerase on some indices of oxidative stress in leucocytes of the rat blood at experimental diabetes mellitus,” Ukr. Biokhim. Zh., 85, No. 1, 62-70 (2013).